A Leap Forward in Oncology
Big Idea
CellmAbs,a spinoff from Lisbon NOVA University, offers an innovative immuno-oncology technology. It develops a new class of immunotherapies to treat solid tumours, particularly in the approach to pancreatic cancer, colorectal cancer, bladder cancer, stomach cancer, breast cancer and other cancers.
Team
Nuno Prego Ramos e Paula Videira.
Portugal Ventures’ Investment Manager
